−33.7
Jasper Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−45.9
FY23:
−52.1
FY24:
−62.6
FY25:
−77.2
Change from FY21 to FY25
millions USD
FY21:
−2.43
FY22:
−0.58
FY23:
−0.27
FY24:
−0.53
FY25:
0.01
Change from FY21 to FY25
millions USD
FY21:
101
FY22:
0.06
FY23:
101
FY24:
47.9
FY25:
34.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−36.1
FY22:
−46.4
FY23:
−52.3
FY24:
−63.2
FY25:
−77.2
All amounts in millions USD